HIV Cure Research Information Sheet
Research into curing HIV infection is ever-changing as new discoveries are made and scientists report additional rare — but informative — cases of individuals likely cured of HIV.
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).
Statement on the UN High Level Meeting on Antimicrobial Resistance Final Draft Political Declaration
Treatment Action Group (TAG) congratulates Malta and Barbados, co-facilitators, and all United Nations (UN) Member States participating in the High-Level Meeting on Antimicrobial Resistance (AMR) upon the publication of the final draft of the Political Declaration.
Broadly Neutralizing Antibodies (bNAbs) and HIV Cure-Related Research
HIV has evolved multiple mechanisms to evade inhibition by antibodies, which are Y-shaped immune system proteins that normally play a key role in fending off or controlling infections.
TB Vaccine Development: The Next Chapter Starts Now
On Thursday, April 13, Treatment Action Group (TAG) presented this webinar about important developments in TB vaccine research.
Why Viral Load Can Be Detectable Despite Perfect Adherence
Webinar on March 22 that will provide an update on new research into cases in which the HIV reservoir generates detectable viral load that cannot be suppressed by antiretroviral therapy.
TB Treatment Trial Results in Context for Communities
On Tuesday, March 14 at 8:00 am ET, join Treatment Action Group (TAG) and Dr. Jennifer Furin for an overview of key results and breakdown of how they fit into the larger TB policy and research landscapes.
Pathways Forward to End HIV: How HIV Cure Research is Helping to Advance HIV Vaccine Research
On September 20, please join Treatment Action Group, Dr. Shelly Karuna, and Dr. Karine Dubé for a webinar on the next generation of bnAbs trial design and ethics related to ATIs in HIV vaccine and cure research.
European Commitments to TB R&D Investments: Promises Made to Be Broken?
In this brief, TAG outlines the pathway the EU can take to scale up support for TB R&D, and advance the many European-sponsored TB vaccine candidates currently in the development pipeline.
Update on HIV Vaccine Research
Developing an HIV vaccine is a difficult scientific challenge, but remains a critical priority. This handout provides an update on HIV vaccine research and a summary of results from the efficacy trials that have been conducted to date, and it…